M&A Deal Summary |
|
|---|---|
| Date | 2020-05-27 |
| Target | Conatus Pharmaceuticals |
| Sector | Life Science |
| Buyer(s) | Histogen |
| Sellers(s) | Bay City Capital |
| Deal Type | Merger |
| Advisor(s) | Oppenheimer & Co. (Financial) Latham & Watkins (Legal) |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2007 |
| Sector | Life Science |
| Employees | 7 |
| Revenue | 4M USD (2022) |
Histogen is a regenerative medicine company developing patented technologies that replace and regenerates tissues in the body. The company’s innovative technology platform utilizes cell-conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells, developing therapeutic products that address underserved, multi-billion US dollar global markets. Histogen was founded in 2007 and is headquartered in San Diego, California.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Merger M&A Deals | 1 of 1 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |
| Category | Venture Capital Firm |
|---|---|
| Founded | 1997 |
| PE ASSETS | 1.3B USD |
| Size | Large |
| Type | Sector Focused |
Bay City Capital LLC was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay City looks for opportunities at all stages of development in biopharmaceuticals, drug discovery, medical devices and diagnostics. Bay City Capital is based in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 60 of 63 |
| Sector: Life Science M&A | 43 of 46 |
| Type: Merger M&A Deals | 3 of 4 |
| State: California M&A | 32 of 33 |
| Country: United States M&A | 57 of 60 |
| Year: 2020 M&A | 2 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-01-07 |
PharmAkea
San Diego, California, United States PharmAkea is a biopharmaceutical company and is a developer of high-quality, small molecule drug candidates against protein targets involved in fibroproliferative diseases. PharmAkea was founded in 2012 and is based in San Diego, California. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-11-01 |
Intarcia Therapeutics
Boston, Massachusetts, United States Intarcia Therapeutics is a biopharmaceutical company applying a targeted approach to the acquisition, development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases. Intarcia Therapeutics is based in Boston, Massachusetts. |
Sell | - |
